Literature DB >> 18753756

Prenatal course and postnatal management of peripheral bronchial atresia: association with congenital cystic adenomatoid malformation of the lung.

William H Peranteau1, Aziz M Merchant, Holly L Hedrick, Kenneth W Liechty, Lori J Howell, Alan W Flake, R Douglas Wilson, Mark P Johnson, Michael W Bebbington, N Scott Adzick.   

Abstract

OBJECTIVE: Peripheral bronchial atresia (PBA), a newly identified fetal lung lesion, is often asymptomatic and managed nonoperatively. However, recent studies suggest that bronchial atresia plays a role in the etiology of microcystic maldevelopment present in congenital cystic adenomatoid malformations (CCAM) which require resection to decrease the risk of infection, pneumothorax and malignant degeneration. The purpose of this study was to evaluate the prenatal radiographic and postnatal computed tomography (CT) scan/pathology findings with attention to the pathologic diagnosis of microcystic maldevelopment in infants with the presumptive diagnosis of PBA.
METHODS: A retrospective review of prenatal and postnatal records of patients diagnosed with fetal lung lesions was performed. Two groups of patients were identified: (1) patients diagnosed with PBA on postnatal CT scan (n = 16), and (2) patients with the pathologically confirmed diagnosis of PBA independent of postnatal CT findings (n = 23).
RESULTS: Prenatal ultrasound diagnosis of these lesions included CCAMs, hybrid lesions, bronchopulmonary sequestrations and bronchial atresia. Eleven of the 16 patients in group 1 with the postnatal radiologic diagnosis of PBA underwent surgical resection, 6 of which were found to have microcystic changes consistent with CCAM. Evaluation of the 23 patients in group 2 with pathologically confirmed PBA identified 65% that had evidence of microcystic maldevelopment consistent with the small cyst type of CCAM.
CONCLUSION: Radiographically diagnosed PBA as well as pathologically confirmed PBA is frequently associated with microcystic changes consistent with the small cyst type of CCAM. Thus, operative management should be considered for PBA to decrease CCAM-associated risks. Copyright 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2008        PMID: 18753756     DOI: 10.1159/000151337

Source DB:  PubMed          Journal:  Fetal Diagn Ther        ISSN: 1015-3837            Impact factor:   2.587


  7 in total

1.  Congenital Cystic Lung Lesions: Redefining the Natural Distribution of Subtypes and Assessing the Risk of Malignancy.

Authors:  Jennifer Pogoriler; Daniel Swarr; Portia Kreiger; N Scott Adzick; William Peranteau
Journal:  Am J Surg Pathol       Date:  2019-01       Impact factor: 6.394

Review 2.  Antenatal management of pulmonary hyperplasia (congenital cystic adenomatoid malformation).

Authors:  D Ankers; N Sajjad; P Green; J L McPartland
Journal:  BMJ Case Rep       Date:  2010-07-21

Review 3.  Fetal ultrasound and magnetic resonance imaging: a primer on how to interpret prenatal lung lesions.

Authors:  Niamh C Adams; Teresa Victoria; Edward R Oliver; Julie S Moldenhauer; N Scott Adzick; Gabrielle C Colleran
Journal:  Pediatr Radiol       Date:  2020-11-30

Review 4.  Imaging findings of bronchial atresia in fetuses, neonates and infants.

Authors:  Leonor Alamo; Yvan Vial; Carole Gengler; Reto Meuli
Journal:  Pediatr Radiol       Date:  2015-12-08

5.  Congenital pulmonary airway malformation mimicking lung cancer: A case report.

Authors:  Ying Zhao; Yongxiang Zhang; Qi Leng; Zhenwu Li; Peng Pang; Xiaoli Qi
Journal:  Medicine (Baltimore)       Date:  2019-06       Impact factor: 1.817

6.  Modified thoracoscopic wedge resection of limited peripheral lesions in S10 for children with congenital pulmonary airway malformation: Initial single-center experience.

Authors:  Rui Guo; Yunpeng Zhai; Shisong Zhang; Huashan Zhao; Hongxiu Xu; Longfei Lv
Journal:  Front Pediatr       Date:  2022-08-18       Impact factor: 3.569

7.  Fetal Congenital Peripheral Bronchial Atresia Diagnosed by Magnetic Resonance Imaging: Two Case Reports.

Authors:  Mitsuru Kozaki; Yuko Iraha; Hitoshi Masamoto; Hayase Nitta; Yukiko Chinen; Tadatsugu Kinjo; Keiko Mekaru; Yoichi Aoki
Journal:  AJP Rep       Date:  2018-10-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.